| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/16/2006 | US20060035365 Method for identifying cellular growth inhibitors |
| 02/16/2006 | US20060035364 combination of high ionic strength and modest osmolarity is achieved using salts of high valency, such as sodium citrate |
| 02/16/2006 | US20060035360 Thermostable DNA polymerases and methods of making same |
| 02/16/2006 | US20060035344 Double-stranded rna structures and constructs, and methods for generating and using the same |
| 02/16/2006 | US20060035335 Use of HCV proteins |
| 02/16/2006 | US20060035331 G-protein coupled receptors |
| 02/16/2006 | US20060035328 Artery-and vein-specific proteins and uses therefor |
| 02/16/2006 | US20060035326 Genes |
| 02/16/2006 | US20060035317 Effect of treatment with 4,5-dihydroxy-2-cyclopenten-1-one (dhcp) on gene expression and quorum-sensing in bacteria |
| 02/16/2006 | US20060035315 Transporters and ion channels |
| 02/16/2006 | US20060035311 Placing a test compound solution in contact with a cell suspension media containing cells, diffusing the test compound solution into the cell suspension from a point source, and detecting activity in the cells with respect to their distance from the point source |
| 02/16/2006 | US20060035310 Media for recovery of microorganism in the presence of antibiotics |
| 02/16/2006 | US20060035309 inoculating a patient sample in a solid medium containing nutrients for the growth, an antibiotic and a chromogenic agent 5-bromo-6-chloro-3-indoxyl-phosphate to detect Staphylococcus aureus |
| 02/16/2006 | US20060035308 Methods and compositions of enzymatic cycling based assays for myeloperoxidase |
| 02/16/2006 | US20060035307 Test strip comprising peptide chain which is cleaved; chromophoric product detected visually; diagnosis of Gastroesophageal reflux disease |
| 02/16/2006 | US20060035306 Used to detect aminopeptidase activity in microorganisms or to determine whether at least one bacterium belongs to the Gram-positive group or to the Gram-negative group according to the color |
| 02/16/2006 | US20060035305 Synthetic peptides, conjugation reagents and methods |
| 02/16/2006 | US20060035304 Methods of oligosaccharide profiling for the detection of cancer |
| 02/16/2006 | US20060035303 JNK3 modulators and methods of use |
| 02/16/2006 | US20060035302 Kinase substrates with multiple phosphorylation sites |
| 02/16/2006 | US20060035301 Method of identifying protein kinase modulators and uses therefore |
| 02/16/2006 | US20060035300 Method of measuring glucose concentration and glucose sensor with the use of glucose dehydrogenase |
| 02/16/2006 | US20060035299 Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases |
| 02/16/2006 | US20060035298 System and method for determining a coagulation parameter |
| 02/16/2006 | US20060035296 Method for detecting acetyltransferase and deacetylase activities and method for screening inhibitors or enhancers of these enzymes |
| 02/16/2006 | US20060035295 Method for determination of thymidine kinase 1 activity and the use thereof |
| 02/16/2006 | US20060035293 Antibodies, polypeptides and polynucleotides, used for detection, prevention and treatment of diseases caused by gramnegative bacteria |
| 02/16/2006 | US20060035286 Monitor protein for measuring processing of protein |
| 02/16/2006 | US20060035275 Nucleic acid diagnostic reagents and methods for detecting nucleic acids, polynucleotides and oligonucleotides |
| 02/16/2006 | US20060035274 Complexity management of genomic DNA |
| 02/16/2006 | US20060035273 hydrodynamics; microfluidics; fluorescence activated cell sorting; electrophoresis |
| 02/16/2006 | US20060035272 Compositions and methods for use in isolation of nucleic acid molecules |
| 02/16/2006 | US20060035271 Reaction chamber roll pump |
| 02/16/2006 | US20060035270 Unique recognition sequences and methods of use thereof in protein analysis |
| 02/16/2006 | US20060035269 Recombinational cloning using engineered recombination sites |
| 02/16/2006 | US20060035268 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements |
| 02/16/2006 | US20060035267 Targets tumor specific antigens; antigens comprise GM2, fucosyl GM1, globo H and N-propionylated polysialic acid conjugated to immunomodulating carrier keyhole limpet hemocyanin, and adjuvant QS-21 or GPI-0100; optimal combination determined by cell surface reactivity; small cell lung cancer |
| 02/16/2006 | US20060035266 selective transport from an aqueous phase to an oil phase; particle size reversibly increased and decreased by irradiation; filter membrane; biodegradable; azo and an azoxy cis-trans isomers reversibly transformed by UV and light |
| 02/16/2006 | US20060035265 In vitro selection and optional indentification of polypeptides using solid support carriers |
| 02/16/2006 | US20060035264 Processes for incorporating nucleic acid sequences into an analyte or library of analytes |
| 02/16/2006 | US20060035263 DRG11-responsive (DRAGON) gene family |
| 02/16/2006 | US20060035262 Dark quenchers for donor-acceptor energy transfer |
| 02/16/2006 | US20060035261 Selective restriction fragment amplification: fingerprinting |
| 02/16/2006 | US20060035260 Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2 and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses |
| 02/16/2006 | US20060035259 Method and apparatus for detecting structural elements of subjects |
| 02/16/2006 | US20060035258 Methods for identifying DNA copy number changes |
| 02/16/2006 | US20060035257 Cleavage of nucleic acids |
| 02/16/2006 | US20060035256 Cleavage of nucleic acids |
| 02/16/2006 | US20060035255 Polynucleotide nanomechanical device that acts as an artificial ribosome and translates DNA signals into polymer assembly instructions |
| 02/16/2006 | US20060035254 Oligonucleotides comprising a modified or non-natural nucleobase |
| 02/16/2006 | US20060035253 Method and apparatus for analysing nucleic acid sequence |
| 02/16/2006 | US20060035252 Methods and workflows for selecting genetic markers utilizing software tool |
| 02/16/2006 | US20060035251 Novel methods for high-throughput genome-wide location analysis |
| 02/16/2006 | US20060035250 Necessary and sufficient reagent sets for chemogenomic analysis |
| 02/16/2006 | US20060035249 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS |
| 02/16/2006 | US20060035248 Assays employing electrochemiluminescent labels and electrochemiluminescence quenchers |
| 02/16/2006 | US20060035247 Biochip with radio frequency identification tag attached thereto, hybridization system, and hybridization management method |
| 02/16/2006 | US20060035246 Chromogenic in situ hybridization methods, kits, and compositions |
| 02/16/2006 | US20060035245 Modulators of enzymatic nucleic acid elements mobilization |
| 02/16/2006 | US20060035244 Method for distinguishing follicular thyroid adenoma (FTA) from follicular thyroid carcinoma (FTC) |
| 02/16/2006 | US20060035243 Multi-step bioassays on modular microfluidic application platforms |
| 02/16/2006 | US20060035242 Prion-specific peptide reagents |
| 02/16/2006 | US20060035241 Method for rapidly detecting quinolone-resistant Salmonella spp. and the probes and primers utilized therein |
| 02/16/2006 | US20060035240 Optimization of gene expression analysis using immobilized capture probes |
| 02/16/2006 | US20060035239 Method and compositions for treating diseases targeting CD51 |
| 02/16/2006 | US20060035238 Composition comprising an array which further comprises chimeric compositions |
| 02/16/2006 | US20060035237 Methods and compositions for categorizing patients |
| 02/16/2006 | US20060035236 DNA fingerprinting for Cannabis sativa (marijuana) using short tandem repeat (STR) markers |
| 02/16/2006 | US20060035235 Signal amplification method for detecting expressed gene |
| 02/16/2006 | US20060035234 detecting molecules and molecular interaction events, retrieving and analyzing analytes, and delivering substances to cells or tissues using probes of the invention |
| 02/16/2006 | US20060035233 Recovery of original template |
| 02/16/2006 | US20060035232 making in vitro peptide expression libraries and for the isolation of nucleotide sequences encoding peptides of interest; constructing and screening DNA libraries for DNA sequences that encode biologically active molecules |
| 02/16/2006 | US20060035231 micro-channels have immobilized thereon a target molecule capable of binding to an analyte present in said sample; immobilized polynucleotides |
| 02/16/2006 | US20060035230 Bacterial effector proteins which inhibit programmed cell death |
| 02/16/2006 | US20060035229 Have 5'-terminal or 3'-terminal areas incorporated stably into the metal oxide layer; freely movable orientation of areas of the unincorporated nucleic acids relative to the metal surface is provide mobility and are are accessible optimally for subsequent processes; coated with uniform orientation |
| 02/16/2006 | US20060035228 Method and test kit for quantitative determination of polynucleotides in a mixture |
| 02/16/2006 | US20060035227 Methods for distinguishing rice varities |
| 02/16/2006 | US20060035226 Amplification of ribonucleic acids |
| 02/16/2006 | US20060035225 Mixing a first probe including a nucleic acid which has a specific region having a sequence complementary to the target sequence and a nonspecific region having a sequence that is not complementary to the target sequence of the target nucleic acid an second probe, detecting a signal of labeling material |
| 02/16/2006 | US20060035224 Purification methods for oligonucleotides and their analogs |
| 02/16/2006 | US20060035222 Methods of nucleic acid amplification |
| 02/16/2006 | US20060035221 Use of the glycine n-acyl transferase (gnat) for the diagnosis and therapy of inflammatory diseases and sepsis |
| 02/16/2006 | US20060035220 Substrate for biomolecule microarray, process for producing the same, biomolecule microarray and method of collecting data on biomolecule microarray |
| 02/16/2006 | US20060035219 Aberrant kallikrein expression |
| 02/16/2006 | US20060035218 For in situ synthesis of oligonucleotide fragments on a solid phase microarray platform and subsequent, "on device" assembly of larger polynucleotides composed of a plurality of shorter oligonucleotide fragments |
| 02/16/2006 | US20060035217 Binary probe and clamp composition. |
| 02/16/2006 | US20060035216 recombinant nucleic acid; isotopic, fluorescent, chemiluminescent, enzymatic, or hapten probe; cloning vector of the nucleic acid; host cell with improved exogenous expression of the nucleic acid; biodegradation; pollution control |
| 02/16/2006 | US20060035215 Incubating sample with probe having secondary structure that changes upon binding; nuclease cleavage; releasing signal generating fragment; kits |
| 02/16/2006 | US20060035214 Screening methods for identifying inhibitors of herpesviral replication |
| 02/16/2006 | US20060035213 POSH nucleic acids, polypeptides and related methods |
| 02/16/2006 | US20060035212 Molecules inhibiting hepatitis c virus protein synthesis and method for screening same |
| 02/16/2006 | US20060035211 Methods for identifying conditions affecting a cell state |
| 02/16/2006 | US20060035210 Method of analyzing metabolism for plant, method of producing labeled plants, labeled plants, and method of measuring NMR for plants |
| 02/16/2006 | US20060035209 Screening method |
| 02/16/2006 | US20060035208 Method for fixing a protein on a pyrrole-based polymer and use thereof for making a sensor |
| 02/16/2006 | US20060034869 Drug for treating liver diseases with the use of hollow protein nanoparticles |
| 02/16/2006 | US20060034867 Administering a vaccine comprising recombinant avipox vector containing and expressing an exogeneous nucleotide sequence encoding FeLV immunogen and an acceptable vehicle or diluent, to a felidae with a liquid jet needle-free injector, wherein the vaccine comprises 104.5-107.0 TCID50/dose |
| 02/16/2006 | US20060034861 HCV E1 comprising specific disulfide bridges |
| 02/16/2006 | US20060034860 Protein-protein interactions in human immunodeficiency virus |
| 02/16/2006 | US20060034843 Interaction of Smad6 with Hox proteins and uses thereof |